(Q40665542)

22 September 2017

1 reference

title

Neuropathobiology of senile dementia and mechanism of action of nootropic drugs (English)

1 reference

22 September 2017

1 reference

1 reference

O Benesová

1

1 reference

22 September 2017

1 April 1994

1 reference

22 September 2017

1 reference

22 September 2017

4

1 reference

22 September 2017

4

1 reference

22 September 2017

285-303

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199404040-00002

22 September 2017

0 references

cites work

A group of potassium-channel blockers-acetylcholine releasers: new potentials for Alzheimer disease? A review

1 reference

12 December 2020

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

12 December 2020

Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.

1 reference

12 December 2020

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

1 reference

12 December 2020

Pharmacological approaches in the treatment of senile dementia

1 reference

12 December 2020

Identification of a family of muscarinic acetylcholine receptor genes

1 reference

12 December 2020

The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease

1 reference

12 December 2020

Piracetam combined with lecithin in the treatment of Alzheimer's disease.

1 reference

12 December 2020

Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

1 reference

12 December 2020

Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.

1 reference

12 December 2020

The expression, localization and functional significance of beta-nerve growth factor in the central nervous system

1 reference

12 December 2020

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

12 December 2020

Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease

1 reference

12 December 2020

Aging: a theory based on free radical and radiation chemistry

1 reference

12 December 2020

Experimental study of long-term administration of cholinesterase inhibitors in aging rats.

1 reference

12 December 2020

Selective vulnerability of brain: new insights from the excitatory synapse

1 reference

12 December 2020

Neuroreceptor changes in Alzheimer disease

1 reference

12 December 2020

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.

1 reference

12 December 2020

CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: a pilot study.

1 reference

12 December 2020

THE INFLUENCE OF THE POSTERIOR AND INTERMEDIATE LOBE OF THE PITUITARY AND PITUITARY PEPTIDES ON THE MAINTENANCE OF A CONDITIONED AVOIDANCE RESPONSE IN RATS.

1 reference

12 December 2020

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

1 reference

12 December 2020

Neuropsychological effects of L-deprenyl in Alzheimer's type dementia.

1 reference

12 December 2020

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine

1 reference

12 December 2020

Free radical involvement in aging. Pathophysiology and therapeutic implications

1 reference

12 December 2020

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

12 December 2020

Memory and cognitive function in man: Does the cholinergic system have a specific role?

1 reference

12 December 2020

Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients

1 reference

12 December 2020

Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study

1 reference

12 December 2020

A Strategy of “Combination Chemotherapy” in Alzheimer's Disease: Rationale and Preliminary Results with Physostigmine plus Deprenyl

1 reference

12 December 2020

The cholinergic system and the excitatory amino acids in Alzheimer's disease

1 reference

12 December 2020

Molecular studies in Alzheimer's disease

1 reference

12 December 2020

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

1 reference

12 December 2020

Chemotherapy of cognitive disorders in geriatric subjects

1 reference

12 December 2020

Effects of prolonged co-dergocrine mesylate (Hydergine) treatment on local cerebral glucose uptake in aged Fischer 344 rats.

1 reference

12 December 2020

Free radicals in medicine. I. Chemical nature and biologic reactions

1 reference

12 December 2020

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

1 reference

12 December 2020

Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates

1 reference

12 December 2020

Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study

1 reference

12 December 2020

Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition.

1 reference

12 December 2020

Effects of phosphatidylserine in age-associated memory impairment.

1 reference

12 December 2020

Tacrine in Alzheimer's disease

1 reference

12 December 2020

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

1 reference

12 December 2020

Treatment for Alzheimer's disease?

1 reference

12 December 2020

Some considerations of different modes of action of nootropic drugs

1 reference

12 December 2020

Molecular Genetics of Alzheimer's Disease

1 reference

12 December 2020

The cholinergic system in old age and Alzheimer's disease

1 reference

12 December 2020

Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functions

1 reference

12 December 2020

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

12 December 2020

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

1 reference

12 December 2020

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

12 December 2020

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

12 December 2020

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

1 reference

12 December 2020

Effects of nerve growth factor on cholinergic brain neurons

1 reference

12 December 2020

Is treating memory impairment in Alzheimer's disease an objective?

1 reference

12 December 2020

Nonsteroidal lazaroid U78517F in models of focal and global ischemia.

1 reference

12 December 2020

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

12 December 2020

Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type

1 reference

12 December 2020

Effects of phosphatidylserine in Alzheimer's disease

1 reference

12 December 2020

Calcium and the aging nervous system

1 reference

12 December 2020

Pharmacological basis for the use of nimodipine in central nervous system disorders

1 reference

12 December 2020

Effects of idebenone on lipid peroxidation and hemolysis in erythrocytes of stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Alzheimer's Disease: Insolubility of Partially Purified Paired Helical Filaments in Sodium Dodecyl Sulfate and Urea

1 reference

12 December 2020

The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl

1 reference

12 December 2020

Complement activation by beta-amyloid in Alzheimer disease

1 reference

12 December 2020

Noradrenergic intervention in Alzheimer's disease

1 reference

12 December 2020

Long-term acetyl-L-carnitine treatment in Alzheimer's disease

1 reference

12 December 2020

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

1 reference

12 December 2020

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

1 reference

12 December 2020

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

1 reference

12 December 2020

Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.

1 reference

12 December 2020

Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes

1 reference

12 December 2020

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

12 December 2020

Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.

1 reference

12 December 2020

Acetyl-1-carnitine. 1: Effects on mortality, pathology and sensory-motor performance in aging rats.

1 reference

12 December 2020

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

12 December 2020

Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: non-N-methyl-D-aspartate receptors

1 reference

12 December 2020

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

1 reference

12 December 2020

Alzheimer's dementia: recent developments in cholinergic pharmacology.

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.

1 reference

12 December 2020

Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype

1 reference

12 December 2020

Localization of a family of muscarinic receptor mRNAs in rat brain

1 reference

12 December 2020

Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B.

1 reference

12 December 2020

Next generation tacrine

1 reference

12 December 2020

Glutamate and other CSF amino acids in Alzheimer's disease

1 reference

12 December 2020

Somatostatin in Alzheimer's disease and depression

1 reference

12 December 2020

AF102B: rational treatment strategy for Alzheimer's disease: recent advances.

1 reference

12 December 2020

"Autocannibalism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis.

1 reference

12 December 2020

Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia

1 reference

12 December 2020

Electron spin resonance spectroscopic demonstration of the hydroxyl free radical scavenger properties of dimethylaminoethanol in spin trapping experiments confirming the molecular basis for the biological effects of centrophenoxine

1 reference

12 December 2020

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.

1 reference

12 December 2020

The evaluation of nootropic drug effects in aging rats.

1 reference

12 December 2020

Human memory and the cholinergic system. A relationship to aging?

1 reference

12 December 2020

Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine

1 reference

12 December 2020

Negative Effects of Tacrine (Tetrahydroaminoacridine) and Methoxytacrine on the Metabolism of Acetylcholine in Brain Slices Incubated Under Conditions Stimulating Neurotransmitter Release

1 reference

12 December 2020

Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.

1 reference

12 December 2020

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.

1 reference

12 December 2020

CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.

1 reference

12 December 2020

Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibition

1 reference

12 December 2020

Effects of long-term Hydergine administration on lipofuscin accumulation in senescent rat brain.

1 reference

12 December 2020

Involvement of free radicals in dementia of the Alzheimer type: a hypothesis

1 reference

12 December 2020

Centrophenoxine increases the rates of total and mRNA synthesis in the brain cortex of old rats: An explanation of its action in terms of the membrane hypothesis of aging

1 reference

12 December 2020

Alterations in total content and solubility characteristics of proteins in rat brain and liver during ageing and centrophenoxine treatment

1 reference

12 December 2020

Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology

1 reference

12 December 2020

Alzheimer's disease: pathology to potential treatments?

1 reference

12 December 2020

Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

1 reference

12 December 2020

Presynaptic cholinergic dysfunction in patients with dementia.

1 reference

12 December 2020

Role of oxygen radicals in stroke: effects of the 21-aminosteroids (lazaroids). A novel class of antioxidants

1 reference

12 December 2020

A membrane hypothesis of aging

1 reference

12 December 2020

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

12 December 2020

Anti-exploratory effect of N-methyl-D-aspartate in elevated plus-maze. Involvement of NMDA and CCK receptors.

1 reference

12 December 2020

Treatment strategies for senile dementia: antagonist beta-carbolines

1 reference

12 December 2020

Selective agents for muscarinic receptors linked to phosphoinositide breakdown

1 reference

12 December 2020

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1 reference

12 December 2020

Historical overview. Calcium, ischemia, and death of brain cells

1 reference

12 December 2020

Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.

1 reference

12 December 2020

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

12 December 2020

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

1 reference

12 December 2020

Excitatory amino acids and Alzheimer's disease

1 reference

12 December 2020

Genetic and molecular advances in Alzheimer's disease

1 reference

12 December 2020

On the role of intracellular physicochemistry in quantitative gene expression during aging and the effect of centrophenoxine. A review

1 reference

12 December 2020

Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices

1 reference

12 December 2020

The cholinergic hypothesis: a historical overview, current perspective, and future directions

1 reference

12 December 2020

Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases

1 reference

12 December 2020

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

1 reference

12 December 2020

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

1 reference

12 December 2020

Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type

1 reference

12 December 2020

Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.

1 reference

12 December 2020

Free radicals in medicine. II. Involvement in human disease

1 reference

12 December 2020

Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.

1 reference

12 December 2020

A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years

1 reference

12 December 2020

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

1 reference

12 December 2020

Protection of cell proteins against free-radical attack by nootropic drugs: scavenger effect of pyritinol confirmed by electron spin resonance spectroscopy

1 reference

12 December 2020

10.2165/00002512-199404040-00002

Identifiers

DOI

1 reference

PubMed ID

8019052

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

8019052